(Q44981536)

7 December 2017

title

Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum (English)

1 reference

7 December 2017

main subject

hepatocellular carcinoma

1 reference

Nafis Shafizadeh

1 reference

7 December 2017

Linda D Ferrell

series ordinal

1 reference

7 December 2017

Sanjay Kakar

series ordinal

1 reference

7 December 2017

publication date

6 June 2008

1 reference

7 December 2017

1 reference

7 December 2017

1 reference

7 December 2017

1 reference

7 December 2017

page(s)

1011-1018

1 reference

Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

Usefulness of the novel oncofetal antigen glypican-3 for diagnosis of hepatocellular carcinoma and melanoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

Glypican-3 immunocytochemistry in liver fine-needle aspirates : a novel stain to assist in the differentiation of benign and malignant liver lesions

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

Morphological changes of early human hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

Glypican-3 as a serum marker for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

'Scirrhous' type hepatocellular carcinomas: a special reference to expression of cytokeratin 7 and hepatocyte paraffin 1

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

Identification of glypican-3 as a novel tumor marker for melanoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

Glypican-3 expression in primary and recurrent ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

Glypican-3 expression in benign liver tissue with active hepatitis C: implications for the diagnosis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.85

7 January 2021

10.1038/MODPATHOL.2008.85

Identifiers

DOI

1 reference

7 December 2017

1 reference